Christopher Causey United Therapeutics Corp (UTHR) insider trading activity

Christopher Causey is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 4,190 shares of UTHR, which is worth approximately $1.95 Million. The most recent transaction as insider was on Jul 07, 2023, when has been sold 1,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.19K

13.87% 3M change

14.01% 12M change

Total Value Held $1.95 Million

CHRISTOPHER CAUSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2023	BUY Exercise of conversion of derivative security	-	1,750 Added 27.62%	4,585 Common Stock
Jan 03 2023	SELL Open market or private sale	$276,260 $276.26 p/Share	1,000 Reduced 26.08%	2,835 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$175,430 $175.43 p/Share	1,000 Added 20.68%	3,835 Common Stock
Nov 03 2022	SELL Open market or private sale	$650,000 $260.0 p/Share	2,500 Reduced 46.86%	2,835 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$438,575 $175.43 p/Share	2,500 Added 31.91%	5,335 Common Stock
Nov 02 2022	SELL Open market or private sale	$1,225,000 $245.0 p/Share	5,000 Reduced 63.82%	2,835 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$877,150 $175.43 p/Share	5,000 Added 48.38%	5,335 Common Stock

Aug 23 2022	SELL Open market or private sale	$787,360 $224.96 p/Share	3,500 Reduced 55.25%	2,835 Common Stock
Aug 23 2022	BUY Exercise of conversion of derivative security	$614,005 $175.43 p/Share	3,500 Added 35.59%	6,335 Common Stock
Jul 08 2022	BUY Exercise of conversion of derivative security	-	2,160 Added 43.24%	2,835 Common Stock
Jun 27 2022	SELL Open market or private sale	$1,183,950 $236.79 p/Share	5,000 Reduced 88.11%	675 Common Stock
Jun 27 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.84%	5,675 Common Stock
May 27 2022	SELL Bona fide gift	-	75 Reduced 10.0%	675 Common Stock
May 26 2022	SELL Open market or private sale	$1,124,100 $224.82 p/Share	5,000 Reduced 86.96%	750 Common Stock
May 26 2022	BUY Exercise of conversion of derivative security	$381,800 $76.36 p/Share	5,000 Added 46.51%	5,750 Common Stock
Aug 06 2021	SELL Open market or private sale	$548,100 $210.0 p/Share	2,610 Reduced 77.68%	750 Common Stock
Aug 06 2021	BUY Exercise of conversion of derivative security	$199,300 $76.36 p/Share	2,610 Added 43.72%	3,360 Common Stock
May 26 2021	SELL Bona fide gift	-	75 Reduced 9.09%	750 Common Stock
Jan 15 2021	SELL Sale (or disposition) back to the issuer	$259,230 $172.82 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 07 2021	SELL Sale (or disposition) back to the issuer	$250,575 $167.05 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 06 2021	SELL Sale (or disposition) back to the issuer	$245,265 $163.51 p/Share	1,500 Reduced 64.52%	825 Common Stock
Jan 06 2021	BUY Exercise of conversion of derivative security	$132,045 $88.03 p/Share	1,500 Added 39.22%	2,325 Common Stock
Jan 05 2021	SELL Sale (or disposition) back to the issuer	$235,155 $156.77 p/Share	1,500 Reduced 64.52%	825 Common Stock

Christopher Causey

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account